期刊文献+

BRCA1和BRCA2在基底细胞样乳腺癌中的表达及意义 被引量:5

Expressions and clinical significance of BRAC1 and BRAC2 in basic-like breast cancer
下载PDF
导出
摘要 目的:探讨BRCA1和BRCA2在基底细胞样型乳腺癌(BLBC)中的表达和相互关系。方法:采用免疫组化法(PV-9000法),检测86例BLBC癌旁组织和BLBC中BRCA1和BRCA2的表达,分析BLBC中BRCA1、BRCA2与临床病理因素间的关系及两者间相互关系。结果:(1)BRCA1在BLBC癌旁组织和BLBC中的表达分别95.3%和51.2%;BRCA2在BLBC癌旁组织及BLBC中的表达分别为96.5%和38.4%,差异有显著性(P<0.05)。(2)BRCA1在不同的年龄、绝经与否、肿块大小及复发和(或)远处转移的BLBC患者中的表达无明显差异(P>0.05),而在组织学分级、TNM分期,淋巴结转移情况不同的BLBC患者间的表达差异有显著性(P<0.05);BRCA2在不同的年龄、肿块大小、组织学分级、TNM分期、淋巴结转移情况及复发和(或)远处转移的BLBC患者间的表达无明显差异(P>0.05),在不同绝经情况的BLBC患者的表达差异有显著性(P<0.05)。(3)BLBC中BRCA1和BRCA2的阳性表达呈负相关(r=-0.234,P<0.05)。结论:BRCA1的和BRCA2在BLBC的发展中起一定的作用,并且BRCA1可作为判断BLBC预后的有效指标。 Objective To explore the expressions of BRACI and BRAC2 in basic-like breast cancer (BLBC) and their relationship. Methods The expressions of BRAC1 and BRAC2 were detected in 86 cases of BLBC tissues and its adjacent tissues by immunohistoehemistry. Their relationship with the elinieal pathological factors was analyzed. Results (1)The positive rate of BRAC1 was 95.3% and 51.2% in BLBC's adjacent tissues and BLBC tissues, respectively. The positive rate of BRAC2 was 96.5% and 38.4% in BLBC's adjacent tissues and BLBC tissues, respectively (P 〈 0.05). (2) BRAC1 expressions were statistically different in patients with different histological grades, TNM grades and lymph node metastasis status (P 〈 0.05). While not statistically different in differenl ages, postmenopause or not, tumor size, relapse and/or distant metastasis in BLBC patients (P 〉 0.05 ).BRAC2 expressions were statistically different in postmenopause or not, while not statistically different in different age, tumor sizes, histological grades, TNM grades, lymph node metastasis status, relapse and/or distant metastasis (P 〉 0.05). (3) BRCA1 expression was correlated with BRAC2expression (r = -0.234, P 〈 0.05). Conclusion BRACl and BRAC2 might eontribule to the progression of BLBC, BRACI could be used as a potential marker for estimating the prognosis of BLBC.
出处 《实用医学杂志》 CAS 北大核心 2011年第3期375-377,共3页 The Journal of Practical Medicine
关键词 乳腺肿瘤 基底细胞样乳腺癌 BRAC1 BRAC2 Breast neoplasms Basal-like breast cancer BRACl BRAC2
  • 相关文献

参考文献10

  • 1King M C, Marks J H, Mandell J B, et al. Breast and ovarian cancer risks due to inherited mutations in BRCAI and BRCA2 [J ]. Science, 2003,302 (5645) : 643-646.
  • 2Livasy C A, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma [J]. Mod Pathol, 2006,19(2) :264-271.
  • 3Tavassoli F A, Devilee P. World Health Organization classification of tumours. Pathology and genetics of tumours of breast and female genital organs[M]. Lyon: IARC Press, 2003 : 10223.
  • 4De Brakeleer S, Bogdani M, de Greve J, et ah Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers [J]. Mutat Res, 2007, 619(122) : 104 -112.
  • 5Yoshikawa K, Honda K, Inamoto T, et al. Reduction of BRCAI protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCAl-associated cases [J]. Clin Cancer Res, 1999,5(6) : 1249-1261.
  • 6Jose P, Emiliano H, Ana O, et al. hnmunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers[J]. Cancer Res, 2003,9(18) :3606-3610.
  • 7Cipollini G, Tommasi S, Paradiso A, et al. Genetic alterations in hereditary breast cancer [J]. Ann Oncol, 2004,15 (11):13- 17.
  • 8Fitz Gerald M G, MacDonald D J, Krainer M, et al. Germ-line BRCAI mutations in Jewish and non-Jewish women with early- onset breast cancer [J]. New Engl Med, 1996,334(3):143- 149.
  • 9陈东祥,李军川,王茁,陈廷煊,张立军,盛波,张吕胜,伍欣星.BRCA2在散发性乳腺癌组织中的表达及意义[J].武汉大学学报(医学版),2007,28(3):359-361. 被引量:15
  • 10王玉林,赵荣宇,张丽芝,关宏伟.BRCA1和BRCA2在乳腺疾病中的表达和意义[J].医师进修杂志(外科版),2005,28(5):13-15. 被引量:11

二级参考文献9

  • 1Easton DF,Ford D,Bishop DT,et al.Breast and ovarian cancer incidence in BRCA1 mutation carriers:breast cancer linkage consortium[J].Am J Hum Genet,1995,56(1):265-271.
  • 2Wooster R,Bignel G,Lancaster J,et al.Identification of the breast cancer susceptibility gene BRCA2.[J].Nature,1995,378(6 559):789-792.
  • 3Alison W.New insights into the biological function of BRCA2 from its structural interactions[J].Breast cancer Res,2003,5(2):107-108.
  • 4Wilson JH,Elledge SJ.BRCA2 enters the fray[J].Science,2002,297(5 588):1 822-1 823.
  • 5Paula V.Breast Cancer-Predisposing genes in Finnish breast and ovarian cancer families[M].Helsinki,2001,14-16.
  • 6Wang X,Wang F,Taniguchi K.Truncating Variants in p53AIP1 Disrupting DNA Damage-Induced Apoptosis Are Associated with Prostate Cancer Risk[J].Cancer Res,2006,66(21):10 302-10 307.
  • 7Marcus JN,Page DL,Watson P,et al.BRCA1 and BRCA2 hereditary breast carcinoma phenotypes[J].Cancer,1997,80:543-556.
  • 8Malian H,Javier B,Jos P.The molecular pathology of hereditary breast cancer:genetic testing and therapeutic implications[J].Modern Pathology,2005,18:1 305-1 320.
  • 9王曦,杨名添,曾益新.乳腺癌易感基因BRCA1和BRCA2的突变检测及其临床意义[J].国外医学(肿瘤学分册),2001,28(1):63-65. 被引量:7

共引文献24

同被引文献61

  • 1李宝江,朱志华,王军业,侯景辉,赵进明,张蓬原,姚广裕,王曦,龙浩,杨名添,戎铁.Ki67、P53、VEGF和C-erbB-2在乳腺癌组织中表达的相关性研究及其临床意义[J].癌症,2004,23(10):1176-1179. 被引量:126
  • 2杨举伦,史爱学,邹红,李涛,杨海捷,蔡琳.乳腺癌发生过程中p53、BRCA1、BRCA2、PTEN、Rb蛋白异常表达[J].临床与实验病理学杂志,2005,21(3):277-281. 被引量:9
  • 3张海添,陆云飞,曾健,林坚,廖清华,万福强.散发性乳腺癌中BRCA1和BRCA2基因突变的研究[J].中华外科杂志,2007,45(7):480-482. 被引量:6
  • 4Lamb P, Grawford L. Characterization of the p53 gene[J]. Mol cell Biol, 1986, 6(5) :1379 -1385.
  • 5Bidard FC, Matthieu MC, Chollet P, et al. P53 status and efficacy of primary anthracyclines/alkylating agent - based regimen according to breast cancer molecular classes [ J ]. Ann Oncol, 2008, 19(7) :1261 - 1265.
  • 6Chambers AF, Matrisian LM. Changing views of the roles of matrix metalloproteinase in matastasis [ J ]. J Nail Cancer Znst, 1997, 89 : 1260 - 1270.
  • 7Kozlowski M, Naumnik W, Niklinski J, et al. Vascular endothelial growth factor C and D expression correlates with lymph node metastasis and poor prognosis in patients with reseccted esophageal cancer [J]. Neoplasma, 2011, 58 (4) :311 -319.
  • 8Takahashi S, Shinya T, Sugiyama A. Angiostatin inhibition of vascular endothelial cells [ J ]. Pharmacol Sci, 2010, 112(4) :432-437.
  • 9Nakamura Y, Yasuoka H, Tsujimoto M, et al. Clinicopathological significance of vascular endothelial growth factor C in breast carcinoma with long term follow up [ J ]. Mod Pathol, 2003, 16(4) :309 -314.
  • 10lhemelandu C U, Leffall L D Jr, Dewitty R L, et al. Molecular breast cancer subtypes in premenopansal and postmenopausal Afri- can-American women : age-specific prevalence and survival [ J ]. J Surg Res, 2007,143(1) :109 -18.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部